Novartis investigational multiple sclerosis therapy Gilenia®* (FTY720) shown ...
istockAnalyst.com (press release) Oral Fingolimod (FTY720) vs Placebo in Relapsing-Remitting Multiple Sclerosis: 24-month Clinical Efficacy Results from a Randomized, Double-Blind, ... |
Novartis investigational multiple sclerosis therapy Gilenia®* (FTY720) shown ... - istockAnalyst.com (press release)
Submitted by Google Search on

Add new comment